Jennifer Gilbride

1.9k total citations · 1 hit paper
8 papers, 1.3k citations indexed

About

Jennifer Gilbride is a scholar working on Rheumatology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Jennifer Gilbride has authored 8 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Oncology and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in Jennifer Gilbride's work include Systemic Lupus Erythematosus Research (5 papers), Bone health and treatments (3 papers) and Bone health and osteoporosis research (3 papers). Jennifer Gilbride is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Bone health and treatments (3 papers) and Bone health and osteoporosis research (3 papers). Jennifer Gilbride collaborates with scholars based in United Kingdom, United States and France. Jennifer Gilbride's co-authors include Robert R. Recker, Claus Christiansen, Pierre D. Delmas, Ralph C. Schimmer, J. A. Stakkestad, Charles H. Chesnut, Arne Høiseth, Dieter Felsenberg, C. H. Chesnut and Ronald Emkey and has published in prestigious journals such as Kidney International, Journal of Bone and Mineral Research and American Journal of Kidney Diseases.

In The Last Decade

Jennifer Gilbride

8 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

2004 877 citations Charles H. Chesnut, Claus Christiansen et al. Journal of Bone and Mineral Research profile →

Peers

Countries citing papers authored by Jennifer Gilbride

Since Specialization

Citations

This map shows the geographic impact of Jennifer Gilbride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Gilbride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Gilbride more than expected).

Fields of papers citing papers by Jennifer Gilbride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Gilbride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Gilbride. The network helps show where Jennifer Gilbride may publish in the future.

Co-authorship network of co-authors of Jennifer Gilbride

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Gilbride. A scholar is included among the top collaborators of Jennifer Gilbride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Gilbride. Jennifer Gilbride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry 2022 ·Birth Defects Research ·Patricia Juliao, Keele Wurst, Jeanne M. Pimenta, (unknown), Helain J. Landy, M. Anthony Moody, Hugh H. Tilson, Deborah L. Covington, (unknown), (unknown), Jennifer Gilbride, Andrew Liu, (unknown), Michelle Petri	18
2	Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population 2022 ·American Journal of Kidney Diseases ·Xueqing Yu, Nan Chen, Junmin Xue, Chi Chiu Mok, Sang‐Cheol Bae, (unknown), Wei Chen, Hong Ren, Xiao Li, Kajohnsak Noppakun, Jennifer Gilbride, (unknown), Beulah Ji, Chang Liu, (unknown), (unknown), (unknown), David A. Roth	28
3	A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis 2021 ·Kidney International ·Brad H. Rovin, Richard Furie, Y K Onno Teng, Gabriel Contreras, Ana Malvar, Xueqing Yu, Beulah Ji, Yulia Green, Tania Gonzalez‐Rivera, Damon Bass, Jennifer Gilbride, (unknown), David A. Roth	112
4	Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus 2021 ·Arthritis & Rheumatology ·Ellen M. Ginzler, (unknown), David D’Cruz, Richard Furie, Kathleen Maksimowicz‐McKinnon, Jim C. Oates, Mittermayer Barreto Santiago, Amit Saxena, Saira Z. Sheikh, Damon Bass, Susan W. Burriss, Jennifer Gilbride, James Groark, Michelle C. Miller, Amy Pierce, David A. Roth, Beulah Ji	72
5	200 Efficacy and safety of belimumab in patients of black race with systemic lupus erythematosus: results from the EMBRACE study 2019 ·Abstracts ·David D’Cruz, Kathleen Maksimowicz‐McKinnon, Jim C. Oates, Mittermayer Barreto Santiago, Damon Bass, Susan W. Burriss, Jennifer Gilbride, James Groark, Michelle C. Miller, Beulah Ji	14
6	Novel ibandronate regimens in postmenopausal osteoporosis: design of the dosing intravenous administration (DIVA) study 2004 ·Osteoporosis International ·Philip N. Sambrook, Jean‐Yves Reginster, R. R. Recker, Ego Seeman, Ranuccio Nuti, S Kelly, Jennifer Gilbride, (unknown)	1
7	Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis breakdown → 2004 ·Journal of Bone and Mineral Research ·Charles H. Chesnut, (unknown), Claus Christiansen, Robert R. Recker, J. A. Stakkestad, Arne Høiseth, Dieter Felsenberg, (unknown), Jennifer Gilbride, Ralph C. Schimmer, Pierre D. Delmas, (unknown)	877
8	Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study 2004 ·Osteoporosis International ·(unknown), Pierre D. Delmas, Robert R. Recker, C. H. Chesnut, (unknown), J. A. Stakkestad, Ronald Emkey, Jennifer Gilbride, Ralph C. Schimmer, Claus Christiansen	207

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact